Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 109010-60-8 | MDL No. : | MFCD03426719 |
Formula : | C16H22N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QTEDVVHLTMELTB-LBPRGKRZSA-N |
M.W : | 290.36 | Pubchem ID : | 6350624 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 84.32 |
TPSA : | 72.63 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.86 cm/s |
Log Po/w (iLOGP) : | 2.62 |
Log Po/w (XLOGP3) : | 1.7 |
Log Po/w (WLOGP) : | 1.25 |
Log Po/w (MLOGP) : | 1.53 |
Log Po/w (SILICOS-IT) : | 1.64 |
Consensus Log Po/w : | 1.75 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.66 |
Solubility : | 0.637 mg/ml ; 0.00219 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.84 |
Solubility : | 0.419 mg/ml ; 0.00144 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.44 |
Solubility : | 0.105 mg/ml ; 0.000363 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1224927-63-2 ]
tert-Butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate
Similarity: 0.76
[ 157115-85-0 ]
(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate
Similarity: 0.74
[ 86499-35-6 ]
3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one
Similarity: 0.72
[ 137088-51-8 ]
1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid
Similarity: 0.69
[ 96-88-8 ]
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
Similarity: 0.69
[ 1224927-63-2 ]
tert-Butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate
Similarity: 0.76
[ 157115-85-0 ]
(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate
Similarity: 0.74
[ 4620-34-2 ]
Ethyl 1,2,3,4-tetrahydroquinoline-2-carboxylate
Similarity: 0.69
[ 58816-69-6 ]
(S)-Ethyl 2-benzamido-3-(4-nitrophenyl)propanoate
Similarity: 0.67
[ 157115-85-0 ]
(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate
Similarity: 0.74
[ 86499-35-6 ]
3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one
Similarity: 0.72
[ 96-88-8 ]
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
Similarity: 0.69
[ 38396-39-3 ]
1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Similarity: 0.69
[ 98717-16-9 ]
(R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide
Similarity: 0.69
[ 86499-35-6 ]
3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one
Similarity: 0.72
[ 209984-30-5 ]
5-Methyl-5H-dibenzo[b,d]azepin-6(7H)-one
Similarity: 0.65
[ 22246-76-0 ]
8-Amino-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
Similarity: 0.63